Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets raise concerns for future of ketamine   
Dr Silver
Dr Ganga de Silva, president of the Society of Companion Animal Practitioners.

WSAVA petition secures over 11,000 signatures

All veterinary surgeries in Sri Lanka would cease to operate if ketamine was not available. That's according to Dr Ganga de Silva, president of the Society of Companion Animal Practitioners of Sri Lanka.

In 2014, China called for a worldwide ban on ketamine following widespread misconception that it is only a ‘recreational drug’. But Dr Silva says that almost all veterinary surgeons in Sri Lanka rely on ketamine for anaesthesia.

"The result would be suffering for animals and it would seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs," she said.

Earlier this year the WSAVA launched an online petition to secure access to ketamine as an essential veterinary medicine. So far, the petition has received over 11,300 signatures - with 15,000 the next milestone.

The petition followed a review by the World Health Organisation that concluded ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic.

This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by support from the global medical and veterinary communities. However, China has since repeated its view that ketamine should fall under international scheduling.

"Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle-income countries," said WSAVA president Dr Walk Ingwersen.

"If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating,” he said.

Dr Nancy Shaffran, president of the International Veterinary Academy of Pain Management, added: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. 

“The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action." 

The WSAVA are continuing with their push to secure the future of ketamine as a veterinary and human medicine. All those interested can sign the petition at http://chn.ge/1RFSou6

Image (C) WSAVA

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.